Back to search

Article

Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma

2025-05-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> In the phase 3 CLEAR study, lenvatinib plus pembrolizumab showed improved efficacy versus sunitinib for patients with clear cell renal cell carcinoma (ccRCC). Previous preclinical studies demonstrated that lenvatinib attenuated tumor-associated macrophage (TAM) infiltration into tumor tissues by inhibiting fibroblast growth factor receptor (FGFR). However, the r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db99ccb8-df2c-586c-9ae6-0fdfda35d118
DOI
10.21203/rs.3.rs-6461270/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinomaDOI 10.21203/rs.3.rs-6461270/v1
Select a neighboring publication to make it the new centre.